So, patients with anti-NMDAR encephalitis present a higher median mRS at 3 months compared to patients with anti-LGI1/CASPR2 encephalitis, although 70% of them recovered mRS <2 at 12 months. This evidence concerns the gene CNTNAP2 and viral encephalitis.